UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 236

Sortiert nach

Fragment-based hit identification: thinking in 3D

Drug discovery today, 2013-12, Vol.18 (23-24), p.1221-1227

2013

Link zum Volltext

Verfügbarkeit prüfen

A simple in vitro assay for assessing the reactivity of nitrile containing compounds

Bioorganic & medicinal chemistry letters, 2009-02, Vol.19 (4), p.1136-1138

2009

Link zum Volltext

Verfügbarkeit prüfen

Lead optimisation of selective non-zinc binding inhibitors of MMP13. Part 2

Bioorganic & medicinal chemistry letters, 2012-01, Vol.22 (1), p.271-277

2012

Link zum Volltext

Verfügbarkeit prüfen

Lead optimisation of pyrazoles as novel FPR1 antagonists

Bioorganic & medicinal chemistry letters, 2012-01, Vol.22 (1), p.532-536

2012

Link zum Volltext

Verfügbarkeit prüfen

Discovery of pyrazoles as novel FPR1 antagonists

Bioorganic & medicinal chemistry letters, 2011-11, Vol.21 (21), p.6456-6460

2011

Link zum Volltext

Verfügbarkeit prüfen

Pharmacokinetic Benefits of 3,4-Dimethoxy Substitution of a Phenyl Ring and Design of Isosteres Yielding Orally Available Cathepsin K Inhibitors

Journal of medicinal chemistry, 2012-10, Vol.55 (20), p.8827-8837

2012

Link zum Volltext

Verfügbarkeit prüfen

Dipeptidyl nitrile inhibitors of Cathepsin L

Bioorganic & medicinal chemistry letters, 2009-08, Vol.19 (15), p.4280-4283

2009

Link zum Volltext

Verfügbarkeit prüfen

Selective non zinc binding inhibitors of MMP13

Bioorganic & medicinal chemistry letters, 2011-07, Vol.21 (14), p.4215-4219

2011

Link zum Volltext

Verfügbarkeit prüfen

Structure-based design of protein tyrosine phosphatase-1B inhibitors

Bioorganic & medicinal chemistry letters, 2005-05, Vol.15 (10), p.2503-2507

2005

Link zum Volltext

Verfügbarkeit prüfen

Design of selective Cathepsin inhibitors

Bioorganic & medicinal chemistry letters, 2009-08, Vol.19 (16), p.4622-4625

2009

Link zum Volltext

Verfügbarkeit prüfen

Novel inhibitors of the αvβ3 integrin—lead identification strategy

Bioorganic & medicinal chemistry letters, 2009-08, Vol.19 (16), p.4832-4835

2009

Link zum Volltext

Verfügbarkeit prüfen

Isosteric replacements for benzothiazoles and optimisation to potent Cathepsin K inhibitors free from hERG channel inhibition

Bioorganic & medicinal chemistry letters, 2012-09, Vol.22 (17), p.5563-5568

2012

Link zum Volltext

Verfügbarkeit prüfen

5-Aminopyrimidin-2-ylnitriles as Cathepsin K inhibitors

Bioorganic & medicinal chemistry letters, 2009-03, Vol.19 (6), p.1658-1661

2009

Link zum Volltext

Verfügbarkeit prüfen

Novel thienopyrrole glycogen phosphorylase inhibitors: Synthesis, in vitro SAR and crystallographic studies

Bioorganic & medicinal chemistry letters, 2006-11, Vol.16 (21), p.5567-5571

2006

Link zum Volltext

Verfügbarkeit prüfen

Abstract 445: A next generation TEAD inhibitor with refined isoform specificity for superior safety & efficacy

Cancer research (Chicago, Ill.), 2023-04, Vol.83 (7_Supplement), p.445-445

2023

Link zum Volltext

Verfügbarkeit prüfen

Diamine containing VLA-4 antagonists

Bioorganic & medicinal chemistry, 2001-08, Vol.9 (8), p.2195-2202

2001

Link zum Volltext

Verfügbarkeit prüfen

Synthesis of N-alkoxybenzimidazoles and N-alkoxypyrimidazoles

Tetrahedron letters, 2002-10, Vol.43 (43), p.7707-7710

2002

Link zum Volltext

Verfügbarkeit prüfen

Near Earth Object impact simulation tool for supporting the NEO mitigation decision making process

Proceedings of the International Astronomical Union, 2006-08, Vol.2 (S236), p.477-486

2006

Link zum Volltext

Verfügbarkeit prüfen

Optimisation and synthesis of libraries derived from phenolic amino acid scaffolds

Tetrahedron letters, 2000-09, Vol.41 (38), p.7405-7408

Morley, Andrew D

2000

Link zum Volltext

Verfügbarkeit prüfen

Allyloxycarbonyl—a useful protecting group for phenolic amino acids and applications on solid support

Tetrahedron letters, 2000-09, Vol.41 (38), p.7401-7404

Morley, Andrew D

2000

Link zum Volltext

Verfügbarkeit prüfen

Synthesis of novel 2,2- and 1,1-linked dimeric ‘head-to-head’ N-alkoxybenzimidazoles

Tetrahedron letters, 2003-01, Vol.44 (3), p.511-513

2003

Link zum Volltext

Verfügbarkeit prüfen

Novel inhibitors of the alphavbeta3 integrin--lead identification strategy

Bioorganic & medicinal chemistry letters, 2009-08, Vol.19 (16), p.4832-4835

2009

Link zum Volltext

Verfügbarkeit prüfen

New non peptidic C5a receptor antagonists

Bioorganic & medicinal chemistry letters, 1997-04, Vol.7 (7), p.907-912

1997

Link zum Volltext

Verfügbarkeit prüfen

Stereoselective cycloadditions of acyl-nitroso compounds; an approach to carbapenem synthesis

Tetrahedron letters, 1990, Vol.31 (7), p.1047-1050

1990

Link zum Volltext

Verfügbarkeit prüfen

1 – 25 von 236

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(229)
Mit Volltextzugriff
(213)

Publikationsform

Sprache

Erscheinungsjahr

n.n

Thema

Science & Technology
(180)
Life Sciences & Biomedicine
(135)
Humans
(122)
Male
(55)
Female
(53)
Biological And Medical Sciences
(48)
Medical Sciences
(48)
Physical Sciences
(43)
Middle Aged
(41)
Aged
(40)
Adult
(30)
General & Internal Medicine
(25)
Animals
(23)
Chemistry
(23)
Chemistry, Organic
(21)
Pharmacology & Pharmacy
(21)
Medicine, General & Internal
(19)
Pharmacology. Drug Treatments
(19)
Science & Technology - Other Topics
(19)
Chemistry, Medicinal
(17)

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(3)

Menü

Weitere Dienste

Einstellungen

Fragment-based hit identification: thinking in 3D

A simple in vitro assay for assessing the reactivity of nitrile containing compounds

Lead optimisation of selective non-zinc binding inhibitors of MMP13. Part 2

(1R,2R)-N-(1-Cyanocyclopropyl)-2-(6-methoxy-1,3,4,5-tetrahydropyrido[4,3-b]indole-2-carbonyl)cyclohexanecarboxamide (AZD4996): A Potent and Highly Selective Cathepsin K Inhibitor for the Treatment of Osteoarthritis

Lead optimisation of pyrazoles as novel FPR1 antagonists

Discovery of pyrazoles as novel FPR1 antagonists

Pharmacokinetic Benefits of 3,4-Dimethoxy Substitution of a Phenyl Ring and Design of Isosteres Yielding Orally Available Cathepsin K Inhibitors

Dipeptidyl nitrile inhibitors of Cathepsin L

Selective non zinc binding inhibitors of MMP13

Structure-based design of protein tyrosine phosphatase-1B inhibitors

Design of selective Cathepsin inhibitors

Novel inhibitors of the αvβ3 integrin—lead identification strategy

Isosteric replacements for benzothiazoles and optimisation to potent Cathepsin K inhibitors free from hERG channel inhibition

5-Aminopyrimidin-2-ylnitriles as Cathepsin K inhibitors

Novel thienopyrrole glycogen phosphorylase inhibitors: Synthesis, in vitro SAR and crystallographic studies

Abstract 445: A next generation TEAD inhibitor with refined isoform specificity for superior safety & efficacy

Diamine containing VLA-4 antagonists

Synthesis of N-alkoxybenzimidazoles and N-alkoxypyrimidazoles

Near Earth Object impact simulation tool for supporting the NEO mitigation decision making process

Optimisation and synthesis of libraries derived from phenolic amino acid scaffolds

Allyloxycarbonyl—a useful protecting group for phenolic amino acids and applications on solid support

Synthesis of novel 2,2- and 1,1-linked dimeric ‘head-to-head’ N-alkoxybenzimidazoles

Novel inhibitors of the alphavbeta3 integrin--lead identification strategy

New non peptidic C5a receptor antagonists

Stereoselective cycloadditions of acyl-nitroso compounds; an approach to carbapenem synthesis

Suchergebnisse filtern